Our Company was originally incorporated as `Sai Dru Syn Laboratories Limited' at Hyderabad, Telangana (erstwhile Andhra Pradesh) as a public limited company under the Companies Act, 1956, pursuant to a certificate of incorporation dated January 25, 1999, issued by the Registrar of Companies, Andhra Pradesh at Hyderabad. Our Company received the certificate of commencement of business from Registrar of Companies, Andhra Pradesh at Hyderabad on February 17, 1999. Subsequently, the name of our Company was changed from `Sai Dru Syn Laboratories Limited' to `Sai Life Sciences Limited' pursuant to a Shareholders' resolution in an extraordinary general meeting held on December 11, 2003 and a fresh certificate of incorporation dated December 16, 2003 consequent to change of name was issued by the Registrar of Companies, Andhra Pradesh at Hyderabad. Thereafter, the name of the Company was changed from `Sai Life Sciences Limited' to `Sai Advantium Pharma Limited' pursuant to a Shareholders' resolution in an extraordinary general meeting held on August 16, 2006 and a fresh certificate of incorporation dated August 30, 2006 consequent to change of name was issued by the Registrar of Companies, Andhra Pradesh at Hyderabad. Subsequently, the name of our Company was changed from `Sai Advantium Pharma Limited' to its present name, `Sai Life Sciences Limited' pursuant to a Shareholders' resolution in an extraordinary general meeting held on April 20, 2012 and a fresh certificate of incorporation dated May 28, 2012 consequent to change of name was issued by the Registrar of Companies, Andhra Pradesh at Hyderabad.Major Events and Milestones:1999- Incorporation of our Company2002- Inauguration of our R&D labs in ICICI Knowledge Park, Hyderabad.2004- Strategic acquisitions of Prasad Drugs Limited, the current Unit III Bolarum Facility2006- Investment by Advantium LLC in our Company to set-up discovery services to expand our Company's business.- Acquired Merrifield Pharma Private Limited2007- Acquisition of shares of our Company held by Advantium LLC by Sequoia Capital India Investments III2008- Investment by MPM Investment Mauritius in our Company2014- Acquisition of shares of our Company held by MPM Investment Mauritius and Sequoia Capital India Investment III by Tata Capital Healthcare Fund 12016- Acquisition of shares of our Company held by MPM Investment Mauritius by HBM Private Equity India and subscription to shares of our Company2019- Opened biology facility in Watertown (Greater Boston, MA) U.S.A2020- Launched Sai Nxt, an initiative aiming to transform the organization into a new generation CDMO- Addition of cellular analysis platforms at our discovery biology facility in Cambridge, Massachusetts, USA2021- Opened new 75,000 sq. ft. discovery biology facility at our integrated R&D campus at Unit II Hyderabad Facility2022- Inauguration of the first set of new discovery chemistry labs as part of the new integrated discovery block at Unit II Hyderabad Facility- Announced the launch of BIOVIA Electronic Lab Notebook application. 2022 -Sai Life Sciences inks strategic agreement to set up Schr”dinger's first dedicated offshore Research Laboratories in India. -Sai Life Sciences wins National Award for Excellence in Energy Management for the third consecutive year. 2023 - Inauguration of high potency API manufacturing block at Unit IV Bidar Facility. -Sai Life Sciences wins Gold in Brandon Hall Group's Excellence in Technology Awards. 2024 - Initiated API developability & formulations (D&F) capabilities at Unit II Hyderabad. -Sai Life Sciences completes restoration of historic Manchirevula stepwell. 2025-The Company Informed Opening of Unit VI, a dedicated facility for Veterinary API production in Bidar, India.